How do stem cells help ischemic cardiomyopathy?

MSCs regenerate damaged heart muscle (myocardium), promote new blood vessel formation in ischemic areas, reduce scar tissue, and improve overall cardiac pumping function in patients with ischemic cardiomyopathy.

Can stem cell therapy improve ejection fraction?

Yes. Clinical studies demonstrate that MSC therapy can improve left ventricular ejection fraction (LVEF) by 5-12% on average, leading to meaningful improvements in heart function and exercise capacity.

What is the treatment process for ischemic cardiomyopathy?

Treatment involves IV infusion of 50-100 million MSCs over 1-2 sessions. Patients undergo cardiac evaluation before and after treatment. Most patients can resume normal activities within 1-2 days.

Ischemic Cardiomyopathy Stem Cell Therapy in Istanbul, Turkey

Stem cell therapy for ischemic cardiomyopathy. MSC treatments regenerate damaged heart muscle, improve cardiac output, and restore heart function after ischemic events.

About Ischemic Cardiomyopathy Stem Cell Therapy in Istanbul

Stem cell therapy for ischemic cardiomyopathy at StemCell Longevita in Istanbul regenerates damaged heart muscle, promotes new blood vessel formation, and improves cardiac function after ischemic injury. Our MSC treatments help patients improve ejection fraction, exercise capacity, and overall heart health.

How Stem Cell Therapy Works for This Condition

Ischemic cardiomyopathy results from heart muscle damage caused by coronary artery disease and heart attacks. MSCs regenerate damaged myocardium, promote angiogenesis in ischemic areas, reduce fibrotic scar tissue, and improve overall cardiac contractility. Clinical studies demonstrate average LVEF improvements of 5-12% after MSC therapy.

Who Is a Candidate?

Patients with reduced ejection fraction due to previous heart attack(s), chronic coronary artery disease with ischemic cardiomyopathy, and heart failure with ischemic etiology. Particularly beneficial for patients who have had optimal revascularization but continue to have reduced cardiac function.

Treatment Process at StemCell Longevita

After cardiac evaluation including echocardiogram and cardiac biomarker review, treatment involves IV MSC infusion of 50-100 million cells. The stem cells home to ischemic and damaged cardiac tissue guided by inflammatory and ischemic signals.

Expected Results & Recovery

Improved ejection fraction (5-12% average increase), enhanced exercise capacity, reduced heart failure symptoms (dyspnea, fatigue, edema), and improved quality of life within 3-6 months. NT-proBNP levels may decrease, indicating improved cardiac function.

Why Choose Turkey for Treatment?

Istanbul's cardiology centers provide comprehensive cardiac evaluation and monitoring. Our cardiac MSC protocols have helped patients improve heart function at costs 60-80% lower than US cardiac rehabilitation programs.

Cost of Treatment

Ischemic cardiomyopathy stem cell therapy from €7,500, including cardiac evaluation, MSC infusion, hotel, transfers, and 12-month cardiac follow-up.

Frequently Asked Questions About Ischemic Cardiomyopathy Stem Cell Therapy

How do stem cells help ischemic cardiomyopathy?: MSCs regenerate damaged heart muscle (myocardium), promote new blood vessel formation in ischemic areas, reduce scar tissue, and improve overall cardiac pumping function in patients with ischemic cardiomyopathy.
Can stem cell therapy improve ejection fraction?: Yes. Clinical studies demonstrate that MSC therapy can improve left ventricular ejection fraction (LVEF) by 5-12% on average, leading to meaningful improvements in heart function and exercise capacity.
What is the treatment process for ischemic cardiomyopathy?: Treatment involves IV infusion of 50-100 million MSCs over 1-2 sessions. Patients undergo cardiac evaluation before and after treatment. Most patients can resume normal activities within 1-2 days.